Status:
COMPLETED
Bridging Pediatric and Adult Biomarkers in Graft-Versus-Host Disease
Lead Sponsor:
Indiana University
Collaborating Sponsors:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Conditions:
Graft-Versus-Host Disease
Eligibility:
All Genders
Brief Summary
This study is designed to collect longitudinal biological samples from patients after hematopoietic cell transplantation (HCT) cared for at multiple bone marrow transplant centers to validate biomarke...
Detailed Description
After informed consent is signed, this study will involve 1) collection of basic HCT data and clinical data available in the medical record and 2) providing blood (and saliva in occasional cases) samp...
Eligibility Criteria
Inclusion
- All patients receiving an allogeneic hematopoietic stem cell transplant, cord blood transplant, bone marrow transplant, T cell depleted marrow, donor lymphocyte infusion (DLI), or donor cellular infusion (DCI) can be included.
Exclusion
- patients not receiving an allogeneic hematopoietic stem cell transplant, cord blood transplant, bone marrow transplant, T cell depleted marrow, donor lymphocyte infusion (DLI), or donor cellular infusion (DCI) will be excluded.
Key Trial Info
Start Date :
January 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2019
Estimated Enrollment :
415 Patients enrolled
Trial Details
Trial ID
NCT02194439
Start Date
January 1 2014
End Date
September 30 2019
Last Update
February 26 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Indiana Unversity Melvin and Bren Simon Cancer Center
Indianapolis, Indiana, United States, 46202